{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:16:47Z","timestamp":1778753807488,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI110264-01A1"],"award-info":[{"award-number":["R21 AI110264-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3738-4","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:03:23Z","timestamp":1549281803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Test and Treat TB: a pilot trial of GeneXpert MTB\/RIF screening on a mobile HIV testing unit in South Africa"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6920-6080","authenticated-orcid":false,"given":"Ingrid V.","family":"Bassett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah S.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Govere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Thulare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone C.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bright","family":"Mhlongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"issue":"18","key":"3738_CR1","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005;19(18):2141\u20138.","journal-title":"AIDS"},{"issue":"6","key":"3738_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.trstmh.2008.10.001","volume":"103","author":"P MacPherson","year":"2009","unstructured":"MacPherson P, et al. Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans R Soc Trop Med Hyg. 2009;103(6):588\u201393.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3738_CR3","unstructured":"World Health Organization. Global Tuberculosis Report 2016. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/250441\/1\/9789241565394-eng.pdf?ua=1\n                    \n                  . Accessed 21 Aug 2017."},{"issue":"Suppl 3","key":"3738_CR4","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1086\/651493","volume":"50","author":"LG Bekker","year":"2010","unstructured":"Bekker LG, Wood R. The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis. 2010;50(Suppl 3):S208\u201314.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3738_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.5588\/ijtld.12.0131","volume":"16","author":"SD Lawn","year":"2012","unstructured":"Lawn SD, Kerkhoff AD, Wood R. Location of Xpert(R) MTB\/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis. 2012;16(5):701 author reply 702.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"3738_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/trstmh\/trw030","volume":"110","author":"KS Chawla","year":"2016","unstructured":"Chawla KS, et al. Policy to practice: impact of GeneXpert MTB\/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Trans R Soc Trop Med Hyg. 2016;110(5):305\u201311.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3738_CR7","doi-asserted-by":"crossref","unstructured":"Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. Impact of Point-of-Care Xpert MTB\/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial. Am J Respir Crit Care Med. 2017;196(7):901\u201310.","DOI":"10.1164\/rccm.201702-0278OC"},{"issue":"9","key":"3738_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139.","journal-title":"N Engl J Med"},{"issue":"15","key":"3738_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/archinternmed.2010.249","volume":"170","author":"E Bendavid","year":"2010","unstructured":"Bendavid E, et al. Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med. 2010;170(15):1347\u201354.","journal-title":"Arch Intern Med"},{"issue":"12","key":"3738_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/cid\/cis750","volume":"55","author":"EH Geng","year":"2012","unstructured":"Geng EH, et al. The effect of a \"universal antiretroviral therapy\" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500\/muL in a public health setting. Clin Infect Dis. 2012;55(12):1690\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3738_CR11","doi-asserted-by":"publisher","first-page":"e43400","DOI":"10.1371\/journal.pone.0043400","volume":"7","author":"G Chamie","year":"2012","unstructured":"Chamie G, et al. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012;7(8):e43400.","journal-title":"PLoS One"},{"issue":"3","key":"3738_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/QAI.0b013e31822e0c4c","volume":"58","author":"D Govindasamy","year":"2011","unstructured":"Govindasamy D, et al. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3738_CR13","volume-title":"District Health Barometer 2014\/15","author":"N Massyn","year":"2015","unstructured":"Massyn N, Peer N, Padarath A, Barron P, Day C. District Health Barometer 2014\/15. Durban: Health Systems Trust; 2015."},{"key":"3738_CR14","unstructured":"Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya D, et al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town: HSRC Press; 2014."},{"key":"3738_CR15","unstructured":"National Tuberculosis and Management Guidelines 2014. South African Department of Health. Available at: \n                    http:\/\/www.tbonline.info\/media\/uploads\/documents\/ntcp_adult_tb-guidelines-27.5.2014.pdf\n                    \n                  . Accessed 30 Aug 2017."},{"issue":"2","key":"3738_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5588\/ijtld.15.0090","volume":"20","author":"L Jeena","year":"2016","unstructured":"Jeena L, Naidoo K. Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care. Int J Tuberc Lung Dis. 2016;20(2):235\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"3738_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/hiv.12115","volume":"15","author":"IV Bassett","year":"2014","unstructured":"Bassett IV, et al. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi township, Durban, South Africa. HIV Med. 2014;15(6):367\u201372.","journal-title":"HIV Med"},{"issue":"8","key":"3738_CR18","doi-asserted-by":"publisher","first-page":"e1001281","DOI":"10.1371\/journal.pmed.1001281","volume":"9","author":"K Kranzer","year":"2012","unstructured":"Kranzer K, et al. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study. PLoS Med. 2012;9(8):e1001281.","journal-title":"PLoS Med"},{"key":"3738_CR19","doi-asserted-by":"crossref","unstructured":"Shapiro AE, van Heerden A, Schaafsma TT, et al. Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda. J Int AIDS Soc. 2018;21(1):e25065.","DOI":"10.1002\/jia2.25065"},{"issue":"3","key":"3738_CR20","doi-asserted-by":"publisher","first-page":"e90754","DOI":"10.1371\/journal.pone.0090754","volume":"9","author":"S Govender","year":"2014","unstructured":"Govender S, et al. CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention. PLoS One. 2014;9(3):e90754.","journal-title":"PLoS One"},{"issue":"4","key":"3738_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/QAI.0b013e318293ae48","volume":"63","author":"K Kranzer","year":"2013","unstructured":"Kranzer K, et al. Community viral load and CD4 count distribution among people living with HIV in a south African township: implications for treatment as prevention. J Acquir Immune Defic Syndr. 2013;63(4):498\u2013505.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"3738_CR22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.7196\/SAMJ.2016.v106i10.10745","volume":"106","author":"EP Budgell","year":"2016","unstructured":"Budgell EP, et al. Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: a retrospective cohort study. S Afr Med J. 2016;106(10):1002\u20139.","journal-title":"S Afr Med J"},{"issue":"3","key":"3738_CR23","doi-asserted-by":"publisher","first-page":"ofx092","DOI":"10.1093\/ofid\/ofx092","volume":"4","author":"SV Shenoi","year":"2017","unstructured":"Shenoi SV, et al. Integrated tuberculosis\/human immunodeficiency virus community-based case finding in rural South Africa: implications for tuberculosis control efforts. Open Forum Infect Dis. 2017;4(3):ofx092.","journal-title":"Open Forum Infect Dis"},{"issue":"9776","key":"3738_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","volume":"377","author":"CC Boehme","year":"2011","unstructured":"Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495\u2013505.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:40:25Z","timestamp":1589456425000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3738-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants provided written consent for study participation. The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (BE421\/14, Durban, South Africa) and the Partners Institutional Review Board (2014P001173, Boston, MA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"110"}}